Literature DB >> 29413776

Inter-observer agreement of the Wagner, University of Texas and PEDIS classification systems for the diabetic foot syndrome.

Alejandra Bravo-Molina1, José Patricio Linares-Palomino2, Blanca Vera-Arroyo3, Luis Miguel Salmerón-Febres2, Eduardo Ros-Díe2.   

Abstract

BACKGROUND: The aim of this cohort study was to assess the inter-observer agreement of three diabetic foot classification systems: the Wagner, the University of Texas and the PEDIS.
METHODS: We included 250 consecutive patients diagnosed of diabetic foot syndrome in 2009-2013. Wound scores were recorded at admission and a reevaluation was performed simultaneously or 24h later by a different evaluator. Demographical, laboratory data and associated risk factors were obtained from the patients' medical records.
RESULTS: The Kappa coefficient showed a moderate inter-observer agreement between the first evaluation and the reevaluation for Wagner scale (Kappa=0.55; 95% CI: 0.507-0.593), University of Texas scale (Kappa=0.513; 95% CI: 0.463-0.563) and for PEDIS scale (Kappa=0.574; 95% CI: 0.522-0.626).
CONCLUSIONS: This moderate agreement shows that these scales should not be used alone for management decisions regarding diabetic foot syndrome and should, therefore, be integrated with other clinical data to ensure an adequate handover.
Copyright © 2016 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amputation; Diabetes complications; Diabetic foot; Inter-observer agreement

Mesh:

Year:  2016        PMID: 29413776     DOI: 10.1016/j.fas.2016.10.009

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  11 in total

1.  ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trial.

Authors:  Jui-Yung Yang; Cha-Chun Chen; Shun-Cheng Chang; Jiun-Ting Yeh; Hui-Fu Huang; Hwang-Chi Lin; Shang-Hsi Lin; Yu-Hsien Lin; Lin-Gwei Wei; Tom J Liu; Shih-Yuan Hung; Hui-Mei Yang; Hui-Hsiu Chang; Chih-Hsin Wang; Yuan-Sheng Tzeng; Chieh-Huei Huang; Chang-Yi Chou; Ying-Sheng Lin; Shih-Yi Yang; Han-Min Chen; Jiun-Tsai Lin; Yi-Fang Cheng; Guang-Huar Young; Chun-Fang Huang; Ya-Chun Kuo; Niann-Tzyy Dai
Journal:  EClinicalMedicine       Date:  2022-07-10

2.  Impact of red cell distribution width and red cell distribution width/albumin ratio on all-cause mortality in patients with type 2 diabetes and foot ulcers: a retrospective cohort study.

Authors:  Jing Hong; Xiang Hu; Wenyue Liu; Xuehua Qian; Feifei Jiang; Zeru Xu; Feixia Shen; Hong Zhu
Journal:  Cardiovasc Diabetol       Date:  2022-06-03       Impact factor: 8.949

3.  Effects of adding adjunctive hyperbaric oxygen therapy to standard wound care for diabetic foot ulcers: a protocol for a systematic review with meta-analysis and trial sequential analysis.

Authors:  Julie Vinkel; Niels Frederich Rose Holm; Janus C Jakobsen; Ole Hyldegaard
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

4.  Pentoxifylline improves the quality of life in type-2 diabetes foot syndrome.

Authors:  Marwan Al-Nimer; Rawa Ratha; Taha Mahwi
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

Review 5.  Clinician Assessment Tools for Patients with Diabetic Foot Disease: A Systematic Review.

Authors:  Raúl Fernández-Torres; María Ruiz-Muñoz; Alberto J Pérez-Panero; Jerónimo C García-Romero; Manuel Gónzalez-Sánchez
Journal:  J Clin Med       Date:  2020-05-15       Impact factor: 4.241

6.  Free Triiodothyronine and Free Triiodothyronine to Free Thyroxine Ratio Predict All-Cause Mortality in Patients with Diabetic Foot Ulcers.

Authors:  Jing Hong; Wen-Yue Liu; Xiang Hu; Wen-Wen Chen; Fei-Fei Jiang; Ze-Ru Xu; Fei-Xia Shen; Hong Zhu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-18       Impact factor: 3.168

7.  Australian guideline on wound classification of diabetes-related foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Emma J Hamilton; Joanna Scheepers; Hayley Ryan; Byron M Perrin; James Charles; Jane Cheney; Stephen M Twigg
Journal:  J Foot Ankle Res       Date:  2021-12-03       Impact factor: 2.303

8.  Infrared thermography for monitoring severity and treatment of diabetic foot infections.

Authors:  Kor H Hutting; Wouter B Aan de Stegge; Rombout R Kruse; Jeff G van Baal; Sicco A Bus; Jaap J van Netten
Journal:  Vasc Biol       Date:  2020-07-21

9.  Predicting the amputation risk for patients with diabetic foot ulceration - a Bayesian decision support tool.

Authors:  Jens Hüsers; Guido Hafer; Jan Heggemann; Stefan Wiemeyer; Swen Malte John; Ursula Hübner
Journal:  BMC Med Inform Decis Mak       Date:  2020-08-24       Impact factor: 2.796

10.  Association between heart rate-corrected QT interval and severe peripheral arterial disease in patients with type 2 diabetes and foot ulcers.

Authors:  Jing Hong; Wen-Yue Liu; Xiang Hu; Fei-Fei Jiang; Ze-Ru Xu; Fang Li; Fei-Xia Shen; Hong Zhu
Journal:  Endocr Connect       Date:  2021-07-26       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.